News | April 01, 2008

Top Colombian Oncology Institution Chooses IntraOp’s Mobetron

April 2, 2008 — IntraOp Medical Corp. received an order for the Mobetron from the Instituto Nacional de Cancerologia, in Bogota, Colombia, marking the first Mobetron in Latin America, as well as the first OR-ready radiation device in South America.

IntraOp’s Mobetron is a mobile electron beam radiation device that applies a direct application of intraoperative electron-beam radiation therapy (IOERT) to a tumor during cancer surgery.

Instituto Nacional de Cancerologia is a public institution with more than 70 years of experience with many diverse oncological diseases. Innovators in the treatment of cancer, the Instituto Nacional de Cancerologia has helped implement techniques for minimally invasive surgery for cancer and other diseases. Its pediatric oncology group is a leader in Colombia and reportedly one of the most highly recognized in Latin America.

The Mobetron enables radiation and surgical oncologists to target the exact area that requires radiation and to deliver high doses of radiation directly to the affected tissue during the cancer surgery. Since the Mobetron is a mobile, self-shielding device, the hospital can move the Mobetron between operating rooms with ease, avoiding the high cost of outfitting radiation rooms to accommodate traditional devices, said the company. Key benefits reportedly include better local tumor control, increased survival rates, shorter treatment cycles and fewer side effects.

For more information:

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...
Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America